Co-Diagnostics, Inc. - 10-Q filing on 2020-05-14

Subsequent Events	3 Months Ended
Mar. 31, 2020
Subsequent Events [Abstract]
Subsequent Events	NOTE 7 – SUBSEQUENT EVENTS On April 8, 2020, we issued 6,069 shares of our common stock for services rendered pursuant to a consulting agreement. The Company evaluated subsequent events pursuant to ASC Topic 855 and has determined that there are no other events that need to be reported.

Subsequent Events

3 Months Ended

Mar. 31, 2020

NOTE 7 – SUBSEQUENT EVENTS

On April 8, 2020, we issued 6,069 shares of our common stock for services rendered pursuant to a consulting agreement.

The Company evaluated subsequent events pursuant to ASC Topic 855 and has determined that there are no other events that need to be reported.